emailContact Us    ASIP Members Access    Become a Supporter    News    Job Seekers/Employers    facebookGoogle+twitterinstagramlinkedinflickr

You can diagnosed buy viagra online was questionable though practicality.

Trusted pharmacy buy Viagra online cheap no prescription
Read the ASIP October Newsletter!


ASIP Companion Meeting at USCAP 2014

Interactive Molecular Pathology 2014
Sunday, March 2, 2014, 1:30 PM - 5:00 PM

Moderators:

  • Dani S. Zander, MD, Milton S. Hershey Medical Center, Penn State College of Medicine, Hershey, PA
  • Karen L. Kaul, MD, PhD, NorthShore University Health System, Evanston, IL

Program:
Download the Presentation Materials for this meeting here PDF

1:30 PM -1:35 PM Introduction to the Interactive Molecular Pathology 2014 Companion Meeting
Mark E. Sobel, MD, PhD, American Society for Investigative Pathology, Bethesda, MD
1:35 PM - 1:50 PM Overview of Small Group Cases
Dani S. Zander, MD, Milton S. Hershey Medical Center, Penn State College of Medicine, Hershey, PA
1:50 PM - 3:00 PM Small Group Case Discussions (concurrent)
  Bladder Cancer
Kevin C. Halling, MD, PhD, Mayo Clinic, Rochester, MN
  Genomic Hematopathology
Richard D. Press, PhD, MD, Oregon Health & Science University, Portland, OR
  Gliomas
Arie Perry, MD, University of California, San Francisco, San Francisco, CA
  Head and Neck Cancer
Jennifer Laudadio, MD, University of Arkansas for Medical Sciences, Little Rock, AR
  Lung Cancer
Neal Lindeman, MD, Brigham and Women's Hospital, Boston, MA
  Molecular Microbiology
Randall J. Olsen, MD, PhD, The Methodist Hospital, Houston, TX
3:00 PM - 3:30 PM Break
3:30 PM - 3:40 PM Overview of Small Group Cases
Karen L. Kaul, MD, PhD, NorthShore University Health System, Evanston, IL
3:40 PM - 4:55 PM Small Group Case Discussions (concurrent)
  Bladder Cancer
Kevin C. Halling, MD, PhD, Mayo Clinic, Rochester, MN
  Genomic Hematopathology
Richard D. Press, PhD, MD, Oregon Health & Science University, Portland, OR
  Gliomas
Arie Perry, MD, University of California, San Francisco, San Francisco, CA
  Head and Neck Cancer
Jennifer Laudadio, MD, University of Arkansas for Medical Sciences, Little Rock, AR
  Lung Cancer
Neal Lindeman, MD, Brigham and Women's Hospital, Boston, MA
  Molecular Microbiology
Randall J. Olsen, MD, PhD, The Methodist Hospital, Houston, TX
4:55 PM - 5:00 PM Panel Discussion/ Questions and Answers
Moderators and All Faculty

 

The topic was determined by the ASIP Task Force on Scientific Events and Special Programs in collaboration with the ASIP Education Committee. Molecular pathology evaluation is becoming increasingly integrated into the practice of anatomic pathology but many practitioners have not been exposed to interactive case studies and therefore lack a full appreciation for the value added by molecular diagnostics. The integration of molecular and genomic pathology into anatomic pathology practice is most conspicuous in oncology, where definition of molecular pathways important for specific tumors has enabled development of drugs to target these pathways, and companion tests to predict which tumors are likely to respond to these targeted agents. Use of molecular testing can also benefit the anatomic pathologist by enhancing accurate pathologic interpretation of samples and confirming the presence of infectious agents. This session will offer an experiential, case-based opportunity to understand and interpret the results of molecular pathology tests in a small group, interactive format. Each small group will be led by an experienced molecular pathologist. Multiple cases requiring a spectrum of types of molecular tests will be used as the medium for participants to choose methods of evaluation appropriate for the clinical scenarios, interpret test results, recognize potential pitfalls, and learn about costs, quality assurance and proficiency testing needs. By the end of this session, participants will have personally constructed interpretative reports for a variety of important molecular pathology tests, and gain knowledge valuable for providing a relevant clinical consultation.